NSE - Delayed Quote INR

Eris Lifesciences Limited (ERIS.NS)

Compare
1,274.65
-46.65
(-3.53%)
At close: 3:30:02 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Amit Indubhushan Bakshi Chairman & MD 48.78M -- 1975
Mr. Sachin Shah Chief Financial Officer -- -- 1980
Mr. Krishnakumar Vaidyanathan Executive Director & COO 44.85M -- 1974
Mr. Gagan Atreja President of Sales & Marketing -- -- 1968
Mr. Inderjeet Singh Negi Executive Director 12.4M -- 1971
Mr. Kaushal Kamlesh Shah Whole Time Director 6.99M -- 1979
Mr. Deepak Kapoor Senior Vice President -- -- 1964
Mr. Milind Talegaonkar Compliance Officer & Company Secretary -- -- --
Mr. Vijay S. Joshi President Medical -- -- 1953
Mr. Manish Kapoor Vice President -- -- 1977

Eris Lifesciences Limited

Shivarth Ambit
Plot No 142/2, Ramdas Road Off SBR Near Swati Bungalows Bodakdev
Ahmedabad, 380054
India
91 79 6966 1000 https://www.eris.co.in
Sector: 
Healthcare
Full Time Employees: 
3,620

Description

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Corporate Governance

Eris Lifesciences Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 19, 2025 at 10:59 AM UTC - May 23, 2025 at 12:00 PM UTC

Eris Lifesciences Limited Earnings Date

Recent Events

February 13, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers